The tariff classification of Marbofloxacin Tablets, Maropitant Citrate Tablets, and Furosemide Tablets in dosage form, from China, Italy, and India, respectively
Reasoning
The tariff classification of Marbofloxacin Tablets, Maropitant Citrate Tablets, and Furosemide Tablets in dosage form, from China, Italy, and India, respectively
Cite this ruling
CBP Ruling N329171 (3004909203): The tariff classification of Marbofloxacin Tablets, Maropitant Citrate Tablets, and Furosemide Tablets in dosage form, from China, Italy, and India, respectively
Paste this into a product's override reason when citing this ruling as justification for a classification.
Other rulings for HS6 300490
The tariff classification of Celexa® in dosage form, from Ireland
Request for Reconsideration of HQ H086082; Tariff Classification of Homeopathic Remedies
The tariff classification of Sildenafil (CAS-139755-83-2), imported in dosage form, from India
The tariff classification of Levetiracetam Oral Solution (CAS-102767-28-2), imported in dosage form, from India
The tariff classification of Levetiracetam (CAS-102767-28-2), imported in dosage form, from India